Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
A study to evaluate the efficacy, safety and tolerability of Remibrutinib versus placebo in adult patients with Generalized Myasthenia Gravis who are on stable, standard-of-care (SOC) treatment.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this myasthenia gravis clinical trial in Los Angeles, CA
If you're searching for myasthenia gravis treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.